-
(-)-Arctigenin MEK1 Inhibitor Workflows
2026-09-15
Use (-)-Arctigenin as a reversible pathway probe to connect LPS–NF-κB signaling, MEK1 activity, and macrophage extracellular-vesicle models. This workflow emphasizes solvent control, time-resolved signaling, and orthogonal validation so an anti-inflammatory agent is not mistaken for a pathway-specific genetic perturbation.
-
Reelin–SFK Signaling Permits Ketamine Action
2026-09-15
The PNAS study shows that Reelin–Apoer2–Src family kinase signaling is a permissive requirement for ketamine-induced hippocampal plasticity and behavioral effects in mice. Its key contribution is distinguishing maintenance of baseline NMDA receptor function from acute ketamine-driven pathway activation, offering a mechanistic framework for incomplete antidepressant response.
-
Biotin-16-UTP: Translating RNA Labels into Insight
2026-09-14
Biotin-16-UTP connects mechanistically informed RNA labeling with practical translational strategy. This thought-leadership article explains how affinity-tagged transcripts support RNA detection, purification, interaction studies, and localization workflows, while positioning recent endogenous-protein biosensor research as a complementary model for building more faithful biological evidence.
-
Calnexin-Dependent Rescue of CFTR Variants
2026-09-14
Tedman et al. use deep mutational scanning to show that calnexin is a variant-dependent determinant of CFTR surface expression and corrector responsiveness across a broad clinical variant set. The study separates proteostasis effects from channel activity, offering a framework for interpreting why F508del CFTR correctors and related modulators perform differently across genotypes.
-
LY2228820: A p38 MAPK Assay-to-Application Guide
2026-09-13
Explore how LY2228820, a selective p38 MAP kinase inhibitor, connects target engagement with inflammation, angiogenesis, and tumor-cell phenotypes. This guide translates pathway evidence into a practical, evidence-aware assay strategy inspired by airway restenosis research.
-
FAISL–FAK Signaling in Triple-Negative Breast Cancer
2026-09-12
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by shielding it from Calpain 2-mediated proteolysis. Its integrated transcriptomic, biochemical, cellular, and mouse-model evidence connects this mechanism to TNBC adhesion, survival, growth, and metastasis, while also supporting FAISL-directed RNA delivery as a research avenue.
-
JXY Reprograms Macrophages in Colitis-Associated CRC
2026-09-12
The reference study shows that Jiedu Xiaozheng Yin limits colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like state through TLR4-associated signaling. Its combination of tumor phenotyping, macrophage functional assays, transcriptional readouts, and pathway antagonism provides a useful framework for studying inflammation-driven tumor progression.
-
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-09-11
This zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn kinase to dopaminergic neuron loss, mitochondrial abnormalities, and microglia-associated inflammation. Its combination of cell-type-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for studying neurodegeneration and designing future functional gene studies.
-
TUNEL Signals in the Pyroptosis Era
2026-09-11
A translational guide to interpreting TUNEL signals alongside pyroptosis biology, with practical strategies for tissue, cell-based, and combination-therapy studies.
-
Epinephrine Bitartrate: Research Workflow Guide
2026-09-10
Build reproducible α- and β-adrenergic experiments with a practical workflow for dose selection, route comparison, pharmacokinetic sampling, and functional readouts. The guide translates canine intranasal findings into assay choices while preserving the limitations of a non-selective agonist.
-
X-Gal Workflows for Cloning and β-Galactosidase Assays
2026-09-10
Use X-Gal to turn lacZα-based clone selection into a rapid visual decision, then extend the same logic to reporter validation and β-galactosidase activity assay workflows. This guide combines practical plating parameters, failure analysis, and a careful connection to activity-dependent receptor biology.
-
Dimethoxy-Tolazoline Derivatives at α-Adrenoceptors
2026-09-09
This 1985 study showed that the position of two methoxy groups on the tolazoline aromatic ring strongly determines α1- and α2-adrenoreceptor efficacy, selectivity, and antagonist activity. By combining isolated-organ pharmacology with radioligand binding, the authors identified distinct derivative profiles that remain useful for interpreting structure–activity relationships and selecting receptor probes.
-
SB203580 Beyond Inhibition: Translational Strategy
2026-09-09
A mechanistic and translational framework for using SB203580 to interrogate p38 signaling, distinguish pathway effects from adaptive resistance, and design more decision-ready experiments.
-
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-09-08
A Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, as a region-specific mediator of schizophrenia-like behaviors in mice. By combining targeted magnetic stimulation with genetic loss- and gain-of-function models, the researchers connect left prelimbic-cortex GABRE regulation to synaptic abnormalities and implicate p62/SQSTM1–GABARAP signaling in the response.
-
v-Agatoxin-IVA and Neuronal Ca Channel Diversity
2026-09-08
Sidach and Mintz showed that v-Agatoxin-IVA remains a high-affinity P-type calcium-channel blocker but also produces low-affinity inhibition of N-type and related high-threshold currents at micromolar exposure. The study demonstrates why toxin concentration, membrane voltage, cell type, and orthogonal current controls must be considered before assigning native neuronal calcium-channel identity.